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Background
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is
believed to confer protection against malaria and its distri-
bution and prevalence are geographically correlated with
malaria endemicity. This enzymopathy has been identified
as the cause of haemolysis following administration of the
antimalarial drug primaquine. Screening for G6PD defi-
ciency prior to administration of primaquine together with
artemisinin combination therapy for treatment or mass-
drug administration is being considered for malaria elimi-
nation. Current conventional methods for G6PD screening
have limitations for field use.
Methods
The WST8/1 -methoxy PMS method, recently adapted to
assay G6PD activity in a 96-well format using dried blood-
spots, was validated using a current gold standard enzy-
matic assay (R&D Diagnostics Ltd®). A study was
conducted to identify prevalence of G6PD deficiency in
Tororo, a highly malaria-endemic region in Uganda. The
performance of the test under various temperature, light,
and storage conditions was evaluated.
Results
The WST8/1-methoxy PMS assay was found to have 72%
sensitivity and 98% specificity when compared to the com-
mercial enzymatic assay. Its calculated AUC was 0.904
suggesting good agreement. Most of the cases misclassified
had borderline values of G6PD activity either between
mild and normal activity values, or between moderate and
severe deficiency values. Other misclassifications were
related to outlier haemoglobin values. Although severe
G6PD deficiency was not found in the area, the test
enabled identification of low G6PD activity. The assay was
found to be highly robust in terms of light sensitivity,
performance under temperature variations, and storage
conditions for bloodspots, assay mixes and tested samples.
Conclusions
The assay was comparable to the currently used standard
enzymatic test, yet offered advantages in terms of cost,
storage, portability, and use in resource-limited settings.
As with other G6PD tests, outlier haemoglobin levels (eg.
as a result of recent haemolytic crises) may confound
G6PD level estimation.
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